War

Arestovich: whether to wait for the end of the war after the death of the President of the Russian Federation

Arestovich: whether to wait for the end of the war after the death of the President of the Russian Federation
Article top vertical

According to Arestovich, Moscow doctors can extend the life of the Russian president for some time.


Russian President Vladimir Putin does have cancer and "a bunch of other diseases."

This was told in an interview with Mark Feygin by Aleksey Arestovich, adviser to the head of the OP.

He clarified that he knew about the diseases of the Kremlin dictator back in 2020. According to Arestovich, Moscow doctors can extend the life of the Russian president for some time.

“I think that the Russian Federation, like the USSR, has no experience and no protocol institutions that allow you to painlessly go through the death of a leader,” Arestovich believes.

He suggested that even after Putin's death, his entourage would still lie to the people for some time and upload pre-recorded videos.

“As soon as Putin dies, someone will actually merge from Putin’s servants or the “Kremlin towers”, the landslide processes of the top will begin ... Well, they can pretend that he is alive for another two weeks. And most importantly, the question will be raised: why at all destroy the American-centric world? I think no one in the military-political leadership will be able to explain why they need a war in Ukraine at all," Arestovich replied.

"After Putin's death, the Russian politicians will understand one thing, Arestovich noted, that they will have to immediately fight for power and influence. The war in Ukraine does not fit into this story," Arestovich believes.

At the same time, the adviser to the head of the Presidential Administration is not sure that the war will stop immediately in this case, but the troops of the Russian Federation will at least stop their zeal.

"Then Ukraine's chances to return Crimea and Donbas will sharply increase," Arestovich added.


Share this article

Facebook Twitter LinkendIn